<DOC>
	<DOCNO>NCT02090179</DOCNO>
	<brief_summary>The purpose study characterize structural abnormality brain integrity blood brain barrier patient mucopolysaccharidosis type IIIB ( MPS IIIB ) .</brief_summary>
	<brief_title>Evaluation Blood Brain Barrier Integrity Structural Abnormalities MPS IIIB Patients Using Multimodal Magnetic Resonance Imaging</brief_title>
	<detailed_description />
	<mesh_term>Mucopolysaccharidosis III</mesh_term>
	<criteria>Subject and/or subject 's parent legal guardian provide informed consent Subject â‰¥5 year age . Subject definitive diagnosis MPS IIIB , determine either documented deficiency alphaNacetylglucosaminidase ( NAGLU ) enzyme activity document functionallyrelevant mutation allele NAGLU gene . The subject internal nonremovable external metal item may present safety risk ( MRI ) , medical condition circumstance MRI contraindicate . The subject know suspected hypersensitivity anaesthesia , bleed disorder , medical condition circumstance lumbar puncture ( collection CSF ) contraindicate . Previous allergic reaction gadoliniumbased MRI contrast medium .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>MPS IIIB</keyword>
	<keyword>Mucopolysaccharidosis</keyword>
	<keyword>Mucopolysaccharidosis type IIIB</keyword>
	<keyword>Sanfilippo Syndrome</keyword>
	<keyword>Metabolism , Inborn Errors</keyword>
	<keyword>Metabolic Diseases</keyword>
	<keyword>Genetic Diseases , Inborn</keyword>
</DOC>